Laurion Capital Management LP Veracyte, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$26.73 - $35.67 $582,901 - $777,855	-21,807 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $425,018 - $612,994	21,807 New	21,807 $565,000
Q1 2020 May 14, 2020	SELL	$16.13 - $30.17 $1.29 Million - $2.41 Million	-79,727 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$20.78 - $29.99 $1.36 Million - $1.96 Million	-65,409 Reduced 45.07%	79,727 $2.23 Million
Q3 2019 Nov 13, 2019	SELL	$23.87 - $30.93 $3.16 Million - $4.09 Million	-132,253 Reduced 47.68%	145,136 $3.48 Million
Q2 2019 Aug 13, 2019	SELL	$22.1 - $28.56 $1.71 Million - $2.21 Million	-77,425 Reduced 21.82%	277,389 $7.91 Million
Q1 2019 May 08, 2019	BUY	$12.0 - $25.76 $4.26 Million - $9.14 Million	354,814 New	354,814 $8.88 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.